STATINS AND BONE HEALTH: A MINI REVIEW

Area of Science:

• Pharmacology
• Bone Biology
• Clinical Medicine

Background:

• Statins are widely prescribed HMG-CoA reductase inhibitors.
• They share mechanistic similarities with anti-resorptive bisphosphonate drugs.
• Emerging evidence suggests statins may possess osteoprotective properties.

Purpose of the Study:

• To explore the mechanisms behind statins' potential bone-protective effects.
• To review clinical evidence on statins and bone health.
• To assess statin impact across various patient populations.

Main Methods:

• Literature review of current research.
• Analysis of mechanistic studies on the mevalonate pathway.
• Synthesis of findings from observational and randomized clinical trials.

Main Results:

• Statins inhibit the mevalonate pathway, similar to bisphosphonates.
• Multiple meta-analyses indicate osteoprotective effects in the general population.
• Ongoing studies investigate these effects in diverse clinical settings.

Conclusions:

• Statins' inhibition of HMG-CoA reductase warrants further investigation for bone health benefits.
• Clinical studies are evaluating the efficacy of statins in preserving bone density and reducing fracture risk.
• Understanding these mechanisms could lead to novel therapeutic strategies for bone diseases.